期刊文献+

阿魏酸钠对小儿先天性心脏病体外循环炎症反应的影响 被引量:3

下载PDF
导出
摘要 将60例小儿先天性心脏病患者随机分为阿魏酸钠组(S组)和对照组(C组)各30例。两组均于体外循环(CPB)下手术,S组在CPB预充液中加入阿魏酸钠注射液8 mg/kg,C组加入等剂量醋酸林格液。分别于体外循环前(T0)、结束(T1)、术后6 h(T2)、术后24 h(T3)抽取血标本,测定血清中肿瘤坏死因子(TNF-α)、白细胞介素6(IL-6)、白细胞介素10(IL-10)的浓度。结果CPB后两组TNF-α、IL-6、IL-10均明显增高,至T2达最高峰;与C组相比,S组T1、T2、T3时TNF-α和IL-6均降低,而IL-10增高。认为阿魏酸钠可通过减少CPB中促炎因子TNF-α和IL-6释放、增加抑炎因子IL-10分泌而减轻体外循环炎症反应。
出处 《山东医药》 CAS 北大核心 2007年第35期45-46,共2页 Shandong Medical Journal
  • 相关文献

参考文献11

  • 1Roth-Isigkeit A, Borstel TV, Seyfarth M, et al. Perioperatlve serum levels of tumour-necrosis-factor alpha (TNF-alpha), IL-1 beta, IL-6, IL-10 and soluble IL-2 receptor in patients undergoring cardiac surgery with cardiopulmonary bypass without and with correction for haemodilution[J]. Clin Exp Immunol, 1999, 118(2) : 242-246. 被引量:1
  • 2Kiuiau A, vandekerckhove F. Cytokines and their interaction with other inflammatory mediators in the pathogenesls of sepsis and septil shock [J]. Eur J clin Invest, 1991,221 (12) : 559-573. 被引量:1
  • 3Holmes J H, Connolly NC, Paull D L, et al. Magnitude of the inflammatory response to cardiopulmonary bupass and its relation to adverse clinical outcomes [ J ]. Inflamm Res, 2002, 51 ( 12 ) : 579- 586. 被引量:1
  • 4龙村主编..体外循环手册 第2版[M].北京:人民卫生出版社,2005:568.
  • 5Reinhart K, Bayer O, Brunkhorst F, et al. Markers of endothdial damage in organ dysfunction and sepsis[J]. Crit Care Med, 2002, 30(5 Suppl) :S302-312. 被引量:1
  • 6Stordeur P, Goldman M. Interleukin-10 as a regulatory cytokine induced by cellular stress: molecular aspects[ J ]. Int Rev Immunol, 1998,16(5-6) : 501-502. 被引量:1
  • 7邓志锋,李明,汪泱,宋书欣.阿魏酸钠对缺血预处理后大鼠脑缺血再灌注损伤的保护作用(英文)[J].中国临床康复,2006,10(8):177-179. 被引量:3
  • 8Kanski J, Aksenova M, Stoyanova A, et al. Ferullc acid antioxidant protection against hydroxyl and peroxyl radical in synaptesomal and neuronal cell culture systems in vitro:structure-activity studles[J]. J Nutr Biochem 2002,13(5) :273-281. 被引量:1
  • 9曲喜英,祝其锋.阿魏酸钠对H_2O_2诱导的PC12细胞凋亡的保护作用的探讨[J].中国药理学通报,2004,20(5):553-556. 被引量:10
  • 10喻东亮,詹锋,徐建军,周琼.阿魏酸钠对体外循环肺保护作用的研究[J].中华胸心血管外科杂志,2005,21(4):241-243. 被引量:7

二级参考文献38

共引文献18

同被引文献21

  • 1胡益勇,徐晓玉.阿魏酸的化学和药理研究进展[J].中成药,2006,28(2):253-255. 被引量:209
  • 2刘季春,康健,邵立建,何明.一氧化氮介导的阿魏酸钠预处理对离体大鼠心脏保护作用[J].中华医学杂志,2006,86(14):987-991. 被引量:11
  • 3Hall R I, Smith M S, Rocker G. The Systemic Inflammatory Response to Cardiopulmonary Bypass: Pathophysiological, Therapeutic, and Pharmacological Considerations[J].Anesth Analg, 1997,85(4) :766-782. 被引量:1
  • 4Bone R C,Balk R A,Cerra F B,et al. Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis[J]. Chest, 1992,101 : 1644-1655. 被引量:1
  • 5Bone R C. Immunologic Dissonance..A Continuing Evolution in Our Understanding of the Systemic Inflammatory Response Syndrome(SIRS) and the Multiple Organ Dysfunction Syndrome(MODS) [J]. Ann Intern Med, 1996,125 : 680-687. 被引量:1
  • 6Gu Y J, Boonstra P W, Graaff R, et al. Pressure Drop, Shear Stress,and Activation of Leukocytes during Cardiopulmonary Bypass:a Comparison between Hollow Fiber and Flat Sheet Membrane Oxygenators[J]. Artif organs, 2000,24 (1) : 43-48. 被引量:1
  • 7Collard C D, Gelman S. Pathophysiology, Clinical Manifestations,and Prevention of Ischemia-reperfusion Injury[J]. Anesthesiology, 2001,94(6) : 1133-1138. 被引量:1
  • 8Kox W J, Volk T, Kox S N, et al. Immunomodulatory Therapies in Sepsis[J]. Intensive Care Med, 2000,26 : 124-128. 被引量:1
  • 9Ueyama K, Nishimura K, Nishina T, et al. PMEA Coating of Pump Circuit and Oxygenator May Attenuate the Early Systemic Inflammatory Response in Cardiopulmonary Bypass Surgery[J]. Asaio J, 2004,50(4): 369-372. 被引量:1
  • 10Brouicki R A, Backer C L, Baden H P, et al. Dexamethosone Reduce the Inflammatory Response to Cardiopulmonary Bypass in Children[J]. Ann Thorac Surg, 2000, 69 (5) : 1490- 1495. 被引量:1

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部